Related Experiment Video
Updated: Aug 13, 2026
04:49
A Modified Technique for Inducing Polycystic Ovary Syndrome in Mice
Published on: July 5, 2024
Quinagolide--a valuable treatment option for hyperprolactinaemia
Anne Barlier1, Philippe Jaquet
1Interactions Cellulaires Neuroendocriniennes, Unite Mixte de Recherche 6544, Centre National de la Recherche Scientifique, Universite de la Mediterranee, Faculte de Medecine Nord, Bd Pierre Dramard, 13916 Marseille Cedex 20, France.
European Journal of Endocrinology
|February 3, 2006
Summary
Hyperprolactinaemia treatment involves dopamine agonists. Quinagolide offers an effective, well-tolerated first-line option with improved compliance and safety compared to older drugs like bromocriptine.
Area of Science:
- Endocrinology
- Pharmacology
Background:
- Hyperprolactinaemia causes gonadal dysfunction and risks osteoporosis if untreated.
- Dopamine agonists are first-line therapy for hyperprolactinaemia.
Purpose of the Study:
- To review the clinical use of quinagolide compared to other dopamine agonists for hyperprolactinaemia.
- To evaluate quinagolide as a potential first-line therapy.
Main Methods:
- Review of clinical data on dopamine agonists for hyperprolactinaemia.
- Comparison of efficacy, adverse events, and patient compliance between bromocriptine, quinagolide, and cabergoline.
Main Results:
- Bromocriptine resistance occurs in 5-18% of patients.
- Quinagolide and cabergoline show improved efficacy and fewer adverse events than bromocriptine.
- Quinagolide offers benefits like simple titration, once-daily dosing, and suitability for pregnancy.
Conclusions:
- Quinagolide is a well-tolerated and effective treatment for hyperprolactinaemia.
- Quinagolide's favorable profile supports its consideration as a first-line therapy.
Related Concept Videos
01:26Pharmaceutical Poisoning: Treatment Strategies
Treatment strategies for poisoning are a critical aspect of emergency medicine, focusing on preventing the absorption of toxins and enhancing their elimination. When a poisoning incident occurs, the first response is to halt exposure and decontaminate the patient, particularly through gastrointestinal (GI) methods if the poison was ingested.Gastrointestinal Decontamination Techniques:Activated charcoal is the cornerstone of GI decontamination. It works through adsorption, binding the toxin to...
01:24Parkinson's Disease: Treatment
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
01:28Drugs Affecting GI Tract Motility: Dopamine Receptor Antagonists
Prokinetic agents are specialized medications that stimulate gastrointestinal (GI) motility, promoting food movement through the GI tract. Dopamine, an inhibitory neurotransmitter, plays a significant role in this process, reducing GI motility and indirectly controlling the speed of digestion. Dopamine receptor antagonists, such as metoclopramide and domperidone, offer a unique advantage as prokinetic agents. By blocking the dopamine receptors, these drugs increase GI motility, improving food...
01:26Cholinergic Antagonists: Therapeutic Uses
Antimuscarinic drugs have various therapeutic applications by inhibiting parasympathetic stimulation in different systems. Here are the key therapeutic uses of antimuscarinics:
Respiratory Tract: Ipratropium, aclidinium, and tiotropium treat asthma, chronic bronchitis, and chronic obstructive pulmonary disease (COPD). They protect against bronchoconstriction caused by irritants like cigarette smoke, sulfur dioxide, and ozone. They also help reduce nasopharyngeal secretions in common...
Respiratory Tract: Ipratropium, aclidinium, and tiotropium treat asthma, chronic bronchitis, and chronic obstructive pulmonary disease (COPD). They protect against bronchoconstriction caused by irritants like cigarette smoke, sulfur dioxide, and ozone. They also help reduce nasopharyngeal secretions in common...
01:11Direct-Acting Cholinergic Agonists: Therapeutic Uses
Direct-acting cholinergic agonists have many therapeutic uses in various medical fields. Choline esters, including acetylcholine, have limited clinical utility due to their non-selectivity and short duration of action. Still, acetylcholine and carbachol are applied topically during ophthalmologic surgery to induce miosis. Pilocarpine, a muscarinic and ganglionic stimulator, effectively treats open-angle glaucoma and alleviates xerostomia and dry mouth caused by radiotherapy or Sjögren syndrome.
01:29Chemotherapy-Induced Nausea and Vomiting: Dopamine Receptor Antagonists
Dopamine receptor antagonists, also known as antipsychotic agents, are critical in managing chemotherapy-induced vomiting. These antiemetic agents block dopamine receptors in the chemoreceptor trigger zone (CTZ), inhibiting signal transmission to the vomiting center. Antipsychotic agents encompass phenothiazines (PTZ), butyrophenones, benzamides, and thienobenzodiazepines (Zyprexa), which are utilized for their antiemetic and sedative properties.
Phenothiazines, such as prochlorperazine...
Phenothiazines, such as prochlorperazine...